3D Printing Material Revenue Soars Nearly 50%, with Both Revenue and Net Profit Surging Over 40%! eSUN Releases 2025 Interim Report

On September 4, 2025, eSUN (Stock Code: 836514), a leading domestic 3D printing material supplier and NEEQ-listed company, released its 2025 interim report. The data reveals that the company achieved RMB 344 million in revenue in the first half of 2025, representing a significant increase of 41.43% year-on-year. Net profit attributable to shareholders reached RMB 27 million, surging 48.60% compared to the same period last year. Both revenue and net profit growth exceeded 40%, demonstrating a dual positive trend of "expanding revenue scale and improving profitability".

3D Printing Material Revenue Surges Nearly 50%

Data reveals that the company's core business—3D printing materials—delivered exceptional performance, with revenue exceeding RMB 300 million and achieving a remarkable 46.95% year-on-year growth. This segment has become the primary engine driving the company's overall operational results.

This growth was primarily driven by the following factors:

1. Effective Product & Market Strategies:

The company consistently pursued product iteration and technological innovation, maintaining a leading advantage in polylactic acid (PLA)-based materials. Notably, it led the development of China’s first 3D printing material international standard (ISO 5425:2023), significantly enhancing its industry influence.

2. E-commerce Channel Expansion:

By deepening its presence on online platforms such as Amazon, the company achieved substantial growth in overseas e-commerce operations, driving overall sales volume. Brand awareness and user loyalty on these platforms improved markedly.

3. Overseas Market Development:

Export revenue reached RMB 293 million, a year-on-year increase of 52.04%, with both offline and online overseas businesses contributing to this growth. The company further expanded its global footprint by establishing a controlled subsidiary in Thailand.

eSUN Showcases at 2025 Formnext Exhibition

According to relevant industry reports, China's additive manufacturing (3D printing) industry is projected to exceed the RMB 100 billion mark by 2027, with an estimated compound annual growth rate (CAGR) of 25.59% during the 2022-2027 period. The industry as a whole is in a phase of rapid development. Against this backdrop, eSUN, leveraging its technological expertise and market presence in the 3D printing materials sector, is fully capitalizing on the industry's growth momentum, injecting strong impetus into its financial performance.

Various 3D Printing Filaments Exhibited by eSUN at Formnext 2025

Beyond 3D printing materials, eSUN's business portfolio also spans the environmentally friendly biodegradable materials sector. Established in 2002, the company has over 20 years of industry expertise, specializing in the R&D, production, and sales of biodegradable materials such as polylactic acid (PLA), polycaprolactone (PCL), and lactate esters. Its products combine environmental sustainability with market competitiveness, aligning with the global trend toward green and low-carbon development.

Business Highlights
3D Printing Filaments

• eSUN launched 11 new 3D printing filaments in the first half of 2025;
• Its PLA-UV Color Change (shifting color in seconds) became a viral innovation in the 3D printing community;
• New TPU flexible products (90A, 85A, 64D) delivered enhanced user experiences;
• PLA Rock and PLA-Clear Series expanded creative possibilities for designers.

Various 3D Printing Filaments Exhibited by eSUN at Formnext 2025

PLA Fiber

• eSUNFiber, in collaboration with industry partners, has successfully addressed challenges related to strength degradation and dyeing difficulties in PLA fibers, achieving a critical breakthrough for the application of PLA fibers in the apparel industry.

Biomedical Materials

• eSUNMed has launched PLA-PEG amphiphilic copolymers, ultra-high molecular weight PLLA, PLGA, and PCL materials, and successfully developed implant-grade PLLA 3D printing filaments;
• The company's medical-grade raw materials, including PLGA and PCL microspheres, have completed Master File registration with the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA).

Core Drivers Behind the Growth

Continued Policy Support:

In 2024, the state issued the Industrial Structure Adjustment Guidance Catalog, listing additive manufacturing (3D printing) in the encouraged category; the Action Plan for Promoting Large-Scale Equipment Upgrades and Consumer Goods Replacement also explicitly supported the application of 3D printing technology. On the other hand, the ongoing "plastic ban" policy continues to drive increased demand for biodegradable materials.

Supply Chain Optimization and Cost Control:

Through the "Dual Increase and Dual Savings" strategy (increase income and savings, increase production and reduce expenditures), the company has optimized inventory and procurement processes, reduced operational costs, and improved capital utilization efficiency.

Dual Drivers of R&D and Branding:

Subsidiary Esun New Material (Xiaogan) Co., Ltd.has been recognized as a "Hubei Provincial Specialized, Refined, Unique, and Innovative Enterprise," among other accolades, affirming its technical capabilities. The company continues to invest in R&D, with R&D expenses reaching RMB 11.0421 million in the first half of 2025, a year-on-year increase of 22.39%.

eSUN's performance in the first half of 2025 was commendable, particularly achieving nearly 50% growth in the 3D printing materials sector, demonstrating the company's strong product capabilities and market adaptability. It is poised to maintain its leading position in both bio-based materials and 3D printing, delivering greater value to investors and the industry.